Tag Archives: DiaMedica Therapeutics Inc.

US IPOs not done yet for 2018 as two foreigners pick Nasdaq for their maiden launch.

The News: Last week, Taiwan Liposome Co. Ltd. (TLC), which is developing lipid formulations of approved drugs for pain and eye disease, raised $22 million by offering 3.75 million ADSs… Read more »

Europe frets over waning IPO biotech scene while US pricings and new registrations keep chugging along.

The News: Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs on the stock markets there prompting speculation that biotech stocks are underperforming, according… Read more »